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Background
A  prevalent  model  of  carcinogenesis  suggests  that 
sequential  activation  of  oncogenes  and  inactivation  of 
tumor  suppressor  genes  occur  in  a  multistep  process 
leading to deviant growth. Over the past decades much 
effort  has  been  put  into  identifying  tumor  suppressor 
genes  and  their  pathways  because  they  represent 
attractive drug targets for cancer therapy. On the basis of 
expression data derived from various human and murine 
tumor tissues, Transforming growth factor-β1 stimulated 
clone-22  (TSC-22)  -  originally  identified  as  a  TGF-β1-
responsive gene [1] - is believed to be a tumor suppressor 
gene  [2-5].  TSC-22  exhibits  pro-apoptotic  functions  in 
cancer cell lines [6,7], and a recent study reported that 
genetic  disruption  of  the  TSC-22  gene  in  mice  causes 
higher  proliferation  and  repopulation  efficiency  of 
hematopoietic precursor cells, consistent with a role of 
TSC-22  in  tumor  suppression  [8].  However,  TSC-22 
knock  out mice do not display enhanced tumorigenesis. 
Because TSC-22 possesses a leucine zipper and a novel 
motif capable of binding DNA in vitro - the TSC-box [9] - 
TSC-22  is  likely  to  operate  as  a  transcription  factor. 
Alter  natively, TSC-22 might act as transcriptional regu-
lator as it binds to Smad4 via the TSC-box and modu  lates 
the transcriptional activity of Smad4 [10]. Further  more, 
Fortilin  (TCTP)  binds  to  and  destabilizes  TSC-22, 
thereby impeding TSC-22-mediated apoptosis [11].
Unraveling  the  precise  mechanism  by  which  TSC-22 
acts is demanding because there are several mammalian 
genes homologous to TSC-22 that could have, at least in 
part, redundant functions. TSC-22 is affiliated with the 
TSC-22 domain family (TSC22DF) consisting of putative 
transcription factors that are characterized by a carboxy-
terminal leucine zipper and an adjacent TSC-box. This 
protein family is conserved from Caenorhabditis elegans 
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mammals,  TSC22D1  to  TSC22D4.  These  loci  produce 
several isoforms that can be subdivided into a short and a 
long  class  depending  on  the  length  of  the  isoform-
specific amino-terminal sequences and depending on the 
presence of two conserved, as-yet-uncharacterized motifs 
in the amino-terminal part of the long isoforms [12,13]. 
In addition to the (partial) redundancy, synergistic and/
or  antagonistic  functions  among  TSC-22  (TSC22D1.2) 
and  its  homologs  are  likely  as  TSC22DF  proteins  can 
form heterodimers [13] and may compete for common 
binding partners or target genes.
The short class of TSC22DF variants, including TSC-22 
(TSC22D1.2), is well studied. In mice, TSC22D2 produces 
several short transcripts that are important for the osmotic 
stress  response  of  cultured  murine  kidney  cells  [14]. 
TSC22D3v2, also known as Gilz (gluco  corticoid-induced 
leucine  zipper),  is  required  in  the  immune  system  for 
T-cell receptor mediated cell death [15-18]. Moreover, Gilz 
is a direct target gene of the transcription factor FoxO3 
[19], and several binding partners of the Gilz protein are 
known, including NF-κB, c-Jun, c-Fos and Raf-1 [20-22]. 
In  addition,  short  isoforms  encoded  by  TSC22D3  have 
differential functions in the aldosterone response, sodium 
homeostasis and proliferation of kidney cells [23].
The function of long TSC22DF members is less well 
understood. The long isoform TSC22D1.1, produced by 
the TSC-22 locus, as well as the long human TSC22D2 
protein are largely uncharacterized. TSC22D4 is impor-
tant for pituitary development [24] and can form hetero-
dimers  with  TSC-22  (TSC22D1.2)  [13].  Functional  in 
vivo studies on TSC22DF, especially on the long isoforms, 
are needed to clarify how TSC-22 (TSC22D1.2) can act 
as a tumor suppressor.
Drosophila melanogaster is a valuable model organism 
for  investigating  the  function  of  TSC22DF  proteins  in 
growth  regulation  for  two  reasons.  First,  many  tumor 
suppressor  genes  [25]  and  growth-regulating  pathways 
[26,27] have been successfully studied in the fly. Second, 
the Drosophila genome contains a single locus, bunched 
(bun), encoding three nearly identical long and five short 
isoforms  of  TSC22DF  members  (FlyBase  annotation 
FB2009_05 [28]). Thus, the redundancy and complexity 
of interactions among TSC22DF proteins are markedly 
lower in Drosophila than in mammals. Drosophila bun is 
important for oogenesis, eye development and the proper 
formation of the embryonic peripheral nervous system 
[29-31]. Furthermore, bun is required for the develop-
ment  of  α/β  neurons  of  the  mushroom  body,  a  brain 
structure involved in learning and memory [32]. It has 
been proposed that bun acts as a mitotic factor during 
the development of α/β neurons.
Two studies that we and others carried out [12,33] have 
demonstrated that, in addition to its role in patterning 
processes, bun plays a crucial role in growth regulation. 
Whereas  the  long  Bun  isoforms  are  positive  growth 
regulators,  genetic  disruption  of  the  short  transcripts 
bunB-E and bunH does not alter growth. However, over-
expression  of  bunB  and  bunC  does  interfere  in  a 
dominant-negative manner with normal bunA function. 
These  results  on  Drosophila  bun  apparently  contradict 
data  describing  mammalian  TSC-22  as  a  growth-
suppres  sing gene. To resolve this conflict, we hypothe-
sized  that  the  as-yet-uncharacterized  long  TSC-22 
isoform (TSC22D1.1) is a functional homolog of BunA in 
growth regulation and that it is antagonized by the short 
isoform TSC22D1.2.
Here we investigate the evolutionary functional conser-
vation between BunA and the human TSC22DF proteins. 
We report that long TSC-22 (TSC22D1.1) as well as the 
long  human  isoforms  TSC22D2  and  TSC22D4  can 
substitute  for  BunA  function  but  the  short  isoforms 
cannot.  In  addition,  we  demonstrate  that  the  growth-
promoting  function  of  BunA  is  -  at  least  in  part  - 
mediated  by  Mlf1  adapter  molecule  (Madm).  We  have 
identified Madm in a genetic screen for growth regulators 
as  well  as  in  a  proteomic  screen  for  BunA-interacting 
proteins, and we show that BunA and Madm cooperate 
in promoting growth during development.
Results
Long human TSC22DF proteins can substitute for BunA in 
Drosophila
We hypothesized that the long isoform encoded by the 
TSC-22  locus,  TSC22D1.1,  is  a  functional  homolog  of 
BunA  with  growth-promoting  capacity,  and  that  it  is 
antagonized by the short isoform TSC22D1.2. Therefore, 
we  tested  whether  human  TSC22D1.1  or  any  other 
TSC22DF member is able to replace BunA function in 
Drosophila.  The  UAS/Gal4  expression  system  [34]  was 
combined with a site-specific integration system [35] to 
express the TSC22DF members. Ubiquitous expression 
of  the  long  -  but  not  of  the  short  -  human  TSC22DF 
isoforms (Figure 1a) resulted in a rescue of the lethality of 
bun mutants carrying a deletion allele (200B) that is likely 
to  be  null  for  all  bun  isoforms  [12]  (Figure  1b).  Thus, 
TSC22D1.1 has the ability to replace BunA function in 
the  fly  whereas  TSC22D1.2  does  not.  Furthermore,  all 
long human TSC22DF isoforms can act in place of BunA 
in Drosophila, suggesting that sequences conserved in the 
long isoforms enable BunA to promote growth.
Madm (Mlf1 adapter molecule) interacts biochemically 
with BunA
How  BunA  exerts  its  growth-regulating  function  is 
unknown.  It  is  conceivable  that  a  protein  specifically 
binding  to  long  TSC22DF  isoforms  accounts  for  the 
growth-promoting ability. Therefore, we set out to identify 
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combining  affinity  purification  and  mass  spectrometry 
(AP-MS) [36,37]. As baits, we expressed green fluores-
cent  protein  (GFP)-  or  hemagglutinin  (HA)-tagged 
versions  of  the  full-length  BunA  protein  (rather  than 
BunA-specific  peptides,  which  might  not  preserve  the 
three-dimensional structure of BunA) in Drosophila S2 
cells and affinity purified the protein complexes by means 
of anti-GFP or anti-HA beads, respectively. The purified 
complexes were analyzed by tandem mass spectrometry 
(LC-MS/MS), and the proteins identified were judged as 
good  candidates  if  they  satisfied  the  following  three 
criteria:  they  were  not  found  in  control  experiments 
(HA-tagged GFP was used as bait and affinity purified 
using  anti-GFP  or  anti-HA  beads);  they  showed  up  in 
several independent AP-MS experiments; and they had 
an identification probability above an arbitrary threshold 
(Mascot  score  50).  We  identified  the  adapter  protein 
Madm as a good candidate in two independent experi-
ments [see Additional file 1].
To  confirm  the  binding  between  Madm  and  BunA, 
inverse pulldown assays using HA-Madm as bait were 
carried out in S2 cells. Endogenous BunA co-immuno-
precipitated  with  HA-tagged  Madm  expressed  under 
the  control  of  a  metallothionein-inducible  promoter 
(Figure  2a).  Moreover,  BunA  showed  up  as  putative 
Madm  binding  partner  in  an  AP-MS  experiment  [see 
Additional file 1].
Assuming that BunA and Madm interact, they should 
at least partially co-localize. Immunofluorescence studies 
in  S2  cells  revealed  that  GFP-BunA  and  HA-Madm 
signals in fact largely overlapped (Figure 2b,c). Interest-
ingly,  the  HA-Madm  signal  was  less  dispersed  when 
GFP-BunA was expressed in the same cell, indicating that 
the interaction with BunA altered the subcellular locali-
za  tion  of  HA-Madm  (Figure  2c).  A  statistical  analysis 
(Materials  and  methods)  revealed  that  HA-Madm  was 
only  localized  in  punctae  when  co-overexpressed  with 
GFP-BunA (100%, n = 50) but not when co-overexpressed 
with  GFP  (0%,  n = 50).  Moreover,  when  a  mutated 
HA-Madm  protein  (R525H,  see  below)  was  expressed, 
the  localization  in  punctae  was  lost  in  66%  of  cells 
co-overexpressing  GFP-BunA  (n = 50).  The  GFP-BunA 
signal  largely  overlapped  with  the  Golgi  marker 
GMAP210 [38] but not with an endoplasmic reticulum 
(ER) marker (Figure 2d, and data not shown), indicating 
that GFP-BunA localizes to the Golgi. The localization of 
BunA and Madm was not dependent on their tag because 
GFP- and HA-tagged BunA and Madm behaved similarly 
(data not shown). Furthermore, GFP-tagged BunA and 
Madm proteins were functional because they rescued the 
lethality of bun and Madm mutants, respectively, when 
expressed  in  the  fly  (Materials  and  methods).  Taken 
together, our AP-MS and co-localization studies demon-
strate that the adapter molecule Madm associates with 
BunA.
Figure 1. Long human TSC22DF isoforms can replace BunA 
function in Drosophila. (a) Schematic drawing of human and 
Drosophila TSC22DF proteins that were tested for their ability to 
rescue the lethality of bun mutants. The long isoforms possess two 
short conserved stretches named motif 1 and motif 2. Whereas 
BunA represents the long TSC22DF isoforms in Drosophila, BunB and 
BunC are two of the short isoforms. (b) Expression of long TSC22DF 
isoforms restores the viability of bun mutants. The quality of the 
rescue is indicated as a percentage of the expected Mendelian 
ratio. The Gal4 driver lines are ordered according to the strength of 
ubiquitous expression they direct during development, with arm-
Gal4 being the weakest and Act5C-Gal4 the strongest driver line. 
In each experimental cross, n ≥ 200 progeny flies were analyzed. 
Leaky expression, without Gal4; 1 c and 2 c, one or two copies of the 
respective UAS construct. The ZH-attP-86Fb integration site seems to 
mediate strong expression as the UAS-attB-bunA constructs (ORF and 
cDNA) do not need to be driven by a Gal4 line for rescue, in contrast 
to the UAS-bunA construct (cDNA) generated by standard P-element-
mediated germline transformation (inserted non-site-specifically 
on chromosome III). Note that too high expression of long TSC22DF 
members is harmful to flies. In a wild-type background, Act5C-
Gal4-directed expression (n ≥ 200) of TSC22D2 and of bunA ORF kills 
the animals (0% survival). Expression from the bunA cDNA construct 
produces few escapers (3%), whereas expression from the bunA cDNA 
P-element construct and of TSC22D4 results in semi-viability (14% and 
69%, respectively). Only TSC22D1.1 can be expressed by Act5C-Gal4 
without compromising survival (>80%). Thus, there appears to be an 
optimal range of long TSC22DF concentration for viability.
  Leaky 
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To  investigate  whether  Madm  binds  to  long-isoform-
specific sequences, we mapped the Madm-binding region 
in  BunA,  and  vice  versa,  by  means  of  co-immuno-
precipitation  (co-IP)  and  yeast  two-hybrid  (Y2H) 
experiments. The advantage of the Y2H system is that 
Drosophila bait proteins are unlikely to form complexes 
or dimers - in case of BunA via its leucine zipper - with 
endogenous  yeast  proteins  and  therefore  the  observed 
Y2H interactions are presumably direct. Our co-IP and 
Y2H data indicated that a long-isoform-specific amino-
terminal  sequence  of  BunA  (amino  acids  475-553) 
encom  passing  motif  2  is  sufficient  for  the  interaction 
with Madm (Figure 2e and Additional file 2). More  over, 
one  of  the  two  point  mutations  isolated  in  a  genetic 
screen that affect motif 2 (the hypomorphic bun alleles 
A-R508W and A-P519L; see Additional data file 4 and 
[12]) weakened the binding to Madm.
The BunA-binding domain in Drosophila Madm was 
reciprocally  mapped  by  means  of  co-IP  and  Y2H 
experiments  to  the  carboxy-terminal  amino  acids  458-
566  (Figure  2f  and  Additional  file  3).  Furthermore,  we 
found  that  amino  acids  530-566,  including  a  nuclear 
export  signal  (NES)  and  a  predicted  nuclear-receptor-
binding motif (LXXLL) in mammals, were not dispen-
sable for the binding to BunA [see Additional file 4]. In 
addition,  a  point  mutation  leading  to  the  arginine  to 
histidine  substitution  R525H  disrupted  BunA-binding 
(the point mutation derived from the Madm allele 4S3; 
Figure 3e). Thus, Madm is a Bun-interacting protein that 
specifically binds the long Bun isoforms.
Drosophila Madm is a growth-promoting gene
In  a  parallel  genetic  screen  based  on  the  eyFLP/FRT 
recombinase  system,  we  were  searching  for  mutations 
that cause growth phenotypes akin to the bunA pheno-
type [12]. A complementation group consisting of seven 
recessive  lethal  mutations  was  mapped  to  the  Madm 
genomic locus (Materials and methods). The seven ethyl 
methanesulfonate  (EMS)-induced  mutations  caused  a 
small head (pinhead) phenotype; therefore, the affected 
gene encodes a positive growth regulator (Figure 3b,c). 
The  rather  compact  genomic  locus  of  Madm  contains 
two exons and produces a single protein isoform (Figure 3e). 
The  adapter  protein  Madm  possesses  a  kinase-like 
domain that lacks the conserved ATP-binding motif, thus 
Figure 2. Madm interacts biochemically with BunA. (a) Western blot showing that endogenous BunA is pulled down together with 
HA-Madm. Anti-HA beads were used to capture either HA-Madm or HA-eGFP as a negative control, respectively. A tenth of the cell lysate was 
used for the input control. (b,c) Co-localization studies of BunA and Madm in Drosophila S2 cells. In (b-b”) a stable cell line capable of producing 
GFP-BunA in every cell was transiently transfected with a plasmid leading to expression of HA-Madm in a subset of cells (and vice versa in c-c”). 
Co-overexpression of GFP-BunA influences the localization of HA-Madm, resulting in a less dispersed pattern (c-c”). (d) GFP-BunA co-localizes with 
the Golgi marker GMAP210 (Golgi microtubule-associated protein of 210 kDa) [38]. (e,f) Schematic drawing of BunA (e) and Madm (f) constructs 
tested in Y2H and co-IP assays for an interaction with full-length Madm and BunA, respectively. The results of the Y2H and co-IP experiments are 
summarized on the left [see Additional files 2 and 3 for the primary results]. The physical interaction of BunA and Madm is mediated by a short 
protein sequence encompassing the conserved motif 2 in BunA and a carboxy-terminal sequence in Madm, respectively [see Additional file 4 for 
alignments].
(b)
(c)
(d)
(b')
(c')
(d')
(b'')
(c'')
(d'')
 GFP-BunA  HA-Madm
 HA-Madm
 GMAP210
Merge
Merge
Merge
 GFP-BunA
 GFP-BunA
5µm
5µm
5µm
(a) (e)
(f)
100 amino acids
BunA
Motif 1 Motif 2 TSC-box leucine zipper
Common region
BunB
Co-IP   Y2H
Yes      ++
Yes       -
Yes      ++
 No        -
Yes      ++
Yes     +++
amino acids 1-1206
amino acids 1035-1206
amino acids 1-990
amino acids 1-475
amino acids 448-990
amino acids 475-553
BunA full-length
C-terminus (BunB full-length)
N-terminus
N-terminal peptide 1
N-terminal peptide 2
Motif 2
dMadm
*
Kinase-like domain (KLD)
Co-IP    Y2H
Yes        +
 No         -
 No         -
Yes       ++
Yes      +++
Yes      +++
Yes      +++
 No         -
 No         -  
amino acids 1-637
amino acids 1-113
amino acids 1-397
amino acids 90-637
amino acids 398-637
amino acids 398-566
amino acids 458-566
amino acids 458-530
R525H
dMadm full-length
N-terminus
N-terminus and KLD
KLD and C-terminus
C-terminus
Mutated full-length
100 amino acids
Input
+
+ _
_
IP: anti-HA
+
+ _
_ HA-Madm
HA-eGFP
Anti-Bun
Anti-HA
Anti-HA
< BunA
< HA-Madm
< HA-eGFP
Western blot
Gluderer et al. Journal of Biology 2010, 9:9 
http://jbiol.com/content/9/1/9
Page 4 of 15rendering it a non-functional kinase [39,40]. Moreover, 
Drosophila Madm carries several conserved NESs and a 
non-conserved nuclear localization signal (NLS; Figure 3e) 
[40]. We identified molecular lesions in all seven EMS-
induced mutations (six point mutations and one deletion; 
Figure 3e) by sequencing the Madm open reading frame 
(ORF). Expression of a genomic Madm as well as of a 
UAS-Madm  construct  was  sufficient  to  rescue  the 
lethality of the seven alleles and one copy of the genomic 
Madm  construct  fully  reverted  the  pinhead  phenotype 
(Materials and methods; Figure 3d), proving that Madm 
mutations caused the growth deficit.
Allelic series of the EMS-induced Madm mutations
To characterize the Madm growth phenotype more closely, 
we first attempted to order the Madm alleles according to 
their strength. To determine the lethal phase of the recessive 
lethal  Madm  EMS-alleles,  they  were  combined  with  a 
deficiency  (Df(3R)Exel7283)  uncovering  the  Madm  locus 
(see also Materials and methods). Development of mutant 
larvae ceased mostly in the third larval instar and in the 
prepupal stage. The onset of the prepupal stage was delayed 
by 2 to 10 days. Alleles 2D2, 2U3, and 3G5 led to strong 
growth deficits, most apparent in L3 larvae, whereas alleles 
3Y2, 4S3, and 7L2 caused almost no reduction in larval size. 
The allele 3T4 turned out to be a hypomorphic allele capable 
of produc  ing few adult flies (less than 10% of the expected 
Mendelian ratio). 3T4 is caused by a point mutation leading 
to a premature translational stop (Figure 3e). However, it 
has been reported that the translation machinery can use 
alternative start codons in human Madm that are located 
further downstream [39]. Alter  native start codons are also 
present  in  Drosophila  Madm  and  may  account  for  the 
hypomorphic nature of the allele 3T4.
Figure 3. A genetic eyFLP/FRT-based screen in Drosophila identifies Madm as a positive growth regulator. (a-d) Dorsal view of mosaic 
heads generated by means of the eyFLP/FRT system. (a) The isogenized FRT82 chromosome used in the genetic screen produces a control mosaic 
head. (b,c) Heads largely homozygous mutant for an EMS-induced Madm mutation display a pinhead phenotype that can be reverted by one 
copy of a genomic Madm rescue construct (d). (e) Graphic representation of the Drosophila Madm protein (top) and gene (bottom). In the protein, 
the BunA-binding region and the NES and NLS sequences are indicated (netNES 1.1 [63], ELM [64], PredictNLS [65]). The seven alleles isolated in 
the genetic screen and the sites of their EMS-induced mutations are in red. Amino acid changes in the protein are indicated. In alleles 3Y2 and 
7L2, the first nucleotide downstream of the first Madm exon is mutated, thus disrupting the splice donor site. In allele 2D2, a deletion causes a 
frameshift after amino acid 385, resulting in a premature translational stop after an additional 34 amino acids. Alleles 3Y2, 4S3, and 7L2 lead to a 
pinhead phenotype of intermediate strength (b) whereas 2D2, 2U3, and 3G5 produce a stronger pinhead phenotype (c). The hypomorphic allele 
3T4 generates a weak pinhead phenotype (data not shown). Genotypes of the flies shown are: (a) y, w, eyFlp/y, w; FRT82B/FRT82B, w+, cl3R3; (b,c) y, w, 
eyFlp/y, w; FRT82B, Madm7L2 or 3G5/FRT82B, w+, cl3R3; (d) y, w, eyFlp/y, w; gen.Madm(LCQ139)/+; FRT82B, Madm3G5/FRT82B, w+, cl3R3.
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alleles,  the  severity  of  the  pinhead  phenotypes  was 
judged. Consistent with the first assay, alleles 2D2, 2U3, 
and 3G5 produced the most severe pinhead phenotypes 
(Figure 3c); alleles 3Y2, 4S3, and 7L2 displayed pinhead 
phenotypes  of  intermediate  strength  (Figure  3b);  and 
allele 3T4 led to a very mild reduction in head and eye 
size in the eyFLP/FRT assay (data not shown).
Like BunA, Madm regulates cell number and cell size
We further characterized the Madm growth phenotype 
by testing effects on cell number and cell size. To assess 
cell  number,  ommatidia  were  counted  in  scanning 
electron microscope (SEM) pictures taken of mosaic eyes 
largely  homozygous  mutant  for  Madm.  Compared  to 
control  mosaic  eyes  (Figure  4a),  Madm  mutant  eyes 
(Figure 4b,c) had significantly fewer ommatidia (Figure 4d). 
To detect changes in cell size, we determined the size of 
rhabdomeres - the light-sensing organelles of the photo-
receptors - in tangential eye sections containing homo  zy-
gous  mutant  clones  (Figure  4a’-c’).  In  addition,  we 
measured the entire cell bodies of photoreceptor cells. 
Madm  mutant  rhabdomeres  and  photoreceptor  cell 
bodies  were  smaller  than  the  controls  (by  29-56%; 
Figure 4e, and data not shown). The reduction was cell-
autonomous  because  only  homozygous  mutant  photo-
receptor cells (marked by the absence of pigmentation) 
were affected.
Furthermore,  the  body  size  of  rare  hypomorphic 
mutant  flies  (produced  with  allele  3T4)  was  reduced 
(Figure  4f),  and  females  were  almost  40%  lighter  than 
controls (Figure 4g). Madm escapers also displayed mal-
for  mations  such  as  eye  and  wing  defects.  Eye  sections 
revealed  rotation  defects,  missing  and  extra  photo-
receptors, fused ommatidia, and cell-fate transformations 
(Figure  4h,  and  data  not  shown).  Similar  patterning 
defects were observed in Madm mutant clones in the eye 
(Figure  4b’,c’).  The  wing  phenotypes  ranged  from  no 
defects to wing notches and an incomplete wing vein V 
(Figure  4i).  All  the  growth  and  patterning  defects  of 
Madm mutant viable flies were reverted by a genomic 
rescue construct (Figure 4f,g; data not shown).
Thus, Madm controls cell number and cell size and also 
controls patterning processes in the eye and the wing. 
These phenotypes strongly resemble phenotypes displayed 
by bunA mutant cells and flies [12] [see Additional file 5 
for wing notches], although the pinhead phenotype and 
the eye-patterning defects caused by the strong Madm 
alleles 2D2 and 3G5 are more severe.
Madm and BunA cooperate to enhance growth
Madm  is  a  growth-promoting  gene  producing  pheno-
types  reminiscent  of  bunA  phenotypes  and  its  gene 
product  physically  interacts  with  BunA.  It  is  thus 
conceivable that the two proteins participate in the same 
complex  to  enhance  growth.  We  tested  for  dominant 
genetic interactions between Madm and bunA in vivo. 
However,  we  did  not  detect  dominant  interactions  in 
hypomorphic mutant tissues or flies (data not shown). 
Thus,  we  hypothesized  that  Madm  and  BunA  form  a 
molecular complex and, as a consequence, the phenotype 
of  the  limiting  complex  component  is  displayed.  This 
hypothesis also implies that overexpression of Madm or 
BunA  alone  would  not  be  sufficient  to  enhance  the 
activity  of  the  complex.  As  previously  reported,  over-
expres  sion of bunA from a UAS-bunA construct did not 
produce  any  overgrowth  phenotypes,  unless  co-over-
expressed with dS6K in a sensitized system in the wing 
[12] (Figure 5b,g). Similarly, with a UAS-Madm trans  genic 
line,  no  obvious  overgrowth  phenotypes  were  observed 
(Figure  5c,h;  Madm  overexpression  caused  patterning 
defects,  Materials  and  methods).  However,  co-over-
expres  sion of bunA and Madm by means of GMR-Gal4 
resulted in larger eyes due to larger ommatidia (Figure 5d,e). 
Consistently, co-overexpression of UAS-Madm together 
with UAS-bunA using a wing driver (C10-Gal4) caused 
an overgrowth phenotype in the wing (Figure 5i,j). We 
observed  additional  tissue  between  the  wing  veins, 
resulting  in  crinkled  wings.  Thus,  Madm  and  BunA 
cooperate to increase organ growth when overexpressed 
during eye and wing development.
Discussion
In the present study, we provide genetic evidence for an 
evolutionarily conserved function of the long TSC22DF 
isoforms in the control of cell and organ size. Because the 
long TSC22DF proteins share two conserved motifs in 
their amino-terminal parts, we set out to identify specific 
binding partners that cooperate with the long isoforms to 
promote  cellular  growth.  The  combination  of  AP-MS 
experiments with a genetic screen for novel mutations 
affecting  growth  [41]  resulted  in  the  identification  of 
Madm  as  a  strong  candidate  for  such  an  interactor, 
illustrating the synergistic forces of the two approaches.
The long TSC22DF proteins promote growth in Drosophila 
via an interaction with Madm
We found that all long - but none of the short - members 
of the human TSC22DF are able to replace the function 
of BunA in the fly. Thus, the potential of long isoforms to 
positively regulate growth has been conserved through 
evolution. Conceivably, the various long isoforms present 
in mammals can, at least to some extent, substitute for 
one  another  and  hence  act  in  a  (partially)  redundant 
manner. However, our rescue experiments in Drosophila 
only  demonstrate  the  potential  of  the  long  human 
TSC22DF  proteins  and  do  not  allow  us  to  draw  any 
conclusions about their endogenous function. Whether 
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growth  regulation  and  whether  the  short  TSC22D1.2 
protein  antagonizes  it  need  to  be  addressed  in  mam-
malian in vivo systems.
The  potential  of  long  human  TSC22DF  proteins  to 
replace  BunA  function  is  likely  to  reside  in  conserved 
sequences  shared  by  all  long  TSC22DF  members. 
Alignments  with  long  TSC22DF  proteins  revealed  two 
short stretches of high conservation [12,13]. Intriguingly, 
two  EMS-induced  mutations  leading  to  amino  acid 
substitutions in the second conserved motif were isolated 
in a genetic screen for mutations affecting growth [12]. 
Figure 4. The Madm loss- or reduction-of-function phenotypes strongly resemble bunA phenotypes. (a-c) Scanning electron micrographs 
of eyFLP/FRT mosaic eyes. (d) Madm mosaic heads (b,c) contain significantly fewer ommatidia than control mosaic heads (a) (n = 6). (a’-c’) Images 
of tangential eye sections showing that Madm mutant (unpigmented) ommatidia (b’,c’) display an autonomous reduction in rhabdomere size 
relative to wild-type sized (pigmented) ommatidia. Furthermore, differentiation defects such as misrotation and missing photoreceptors are 
observed in Madm mutant ommatidia. Clones were induced 24-48 h after egg deposition using the hsFLP/FRT technique. (e) Rhabdomere size 
of Madm-mutant ommatidia is significantly reduced (by 29-56%). The area enclosed by rhabdomeres of photoreceptors R1-R6 in unpigmented 
mutant ommatidia was compared to the area measured in pigmented wild-type sized ommatidia. For each genotype, three pairs of ommatidia 
without differentiation defects from three different eye sections were measured (n = 9). Significant changes are marked by asterisks, **p < 0.01 and 
***p < 0.001 (Student’s t-test) in (d) and (e). (f) Heteroallelic combinations of the hypomorphic Madm allele 3T4 produce few viable small flies (<10% 
of the expected Mendelian ratio) that can be rescued by one copy of a genomic Madm rescue construct. (g) The dry weight of Madm hypomorphic 
females is reduced by 37% compared to control flies (Df/+). One copy of a genomic rescue construct restores normal weight. The genomic rescue 
construct has no significant dominant effect on dry weight (‘rescue Df/+’ females do not significantly differ from ‘Df/+’ females). n = 15, except for 
Df/3T4 (n = 9). (h) Tangential section of an eye from a Madm hypomorphic mutant female displaying rotation defects (yellow asterisk), missing 
rhabdomeres (green asterisk), and cell-fate transformations (red asterisk). (i) Wings of hypomorphic Madm males exhibiting wing notches and an 
incomplete wing vein V (arrows). Genotypes are: (a,a’) y, w, eyFlp or hsFlp/y, w; FRT82B/FRT82B, w+, cl3R3 or M. (b,b’,c,c’) y, w, eyFlp or hsFlp/y, w; FRT82B, 
Madm7L2 or 3G5/FRT82B, w+, cl3R3 or M; (Df/+) y, w; FRT82B/Df(3R)Exel7283; (Df/3T4) y, w; FRT82B, Madm3T4/Df(3R)Exel7283; (rescue Df/3T4) y, w; gen.
Madm(LCQ139)/+; FRT82B, Madm3T4/Df(3R)Exel7283; (rescue Df/+) y, w; gen.Madm(LCQ139)/+; FRT82B/Df(3R)Exel7283.
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morphs  that  were  recessive  lethal  and  caused  severe 
growth  deficits.  BunA  binds  via  the  second  conserved 
motif to Madm and at least one mutation weakens the 
binding but does not abolish it. As the motif 2 is present 
in all long TSC22DF isoforms, it is likely that all of them 
can  bind  Madm.  In  fact,  the  long  human  isoform 
TSC22D4 is able to do so, as uncovered in a large-scale 
Y2H  study  [42,43].  So  far,  we  could  not  assign  any 
function to the first conserved motif. Because this motif 
is  heavily  phosphorylated  [44],  we  speculate  that  it  is 
important for the regulation of BunA activity.
Because short isoforms can heterodimerize with long 
isoforms,  as  reported  for  TSC-22  (TSC22D1.2)  and 
TSC22D4 [13], they may interact indirectly with Madm. 
This  could  explain  why  human  Madm  was  found  to 
interact with the bait protein TSC-22 (TSC22D1.2) in a 
high-throughput analysis of protein-protein interactions 
by immunoprecipitation followed by mass spectrometry 
(IP/MS)  [43,45].  Moreover,  we  found  that  the  short 
isoform BunB interacts with Drosophila Madm in a co-IP 
but not in a Y2H assay. Heterodimers of BunA and short 
Bun  isoforms  exist  in  Drosophila  S2  cells  because  we 
found  that  a  small  fraction  of  endogenous  BunA  did 
co-immunoprecipitate  with  tagged  BunB  and  BunC 
versions (data not shown). However, we failed to identify 
short Bun isoforms as BunA heterodimerization partners 
in the AP-MS experiments. One possible explanation is 
that the peptides specific for short Bun isoforms are very 
low abundant. This might also explain why they were not 
detected when a catalog of the Drosophila proteome was 
generated [46].
In mammalian cells, both IP/MS and Y2H experiments 
provided  evidence  for  a  physical  interaction  between 
Madm and TSC22DF proteins [42,43]. Our study extends 
these  findings  in  two  ways.  We  demonstrate  that  only 
long TSC22DF proteins directly bind to Madm, and we 
also  provide  evidence  for  the  biological  significance  of 
this interaction in growth control.
Biological functions of Madm
Madm  has  been  implicated  in  ER-to-Golgi  trafficking 
because  overexpression  of  Madm  affected  the  intra-
cellular transport of a Golgi-associated marker in COS-1 
cells [47]. In addition, Madm localizes to the nucleus, the 
cytoplasm and Golgi membranes in Drosophila, and an 
Figure 5. Co-overexpression of Madm and bunA causes overgrowth. (a-d) Scanning electron micrographs of adult eyes as a readout for 
the consequences of overexpression of bunA and Madm under the control of the GMR-Gal4 driver line late during eye development. Whereas 
expression of (b) bunA or (c) Madm singly does not cause a size alteration compared to the control (a), overexpression of both leads to increased 
eye size (d). (e) The size increase on bunA and Madm coexpression is due to larger ommatidia (Student’s t-test, n = 9, ***p < 0.001). (f-i) The growth-
promoting effect of bunA and Madm co-overexpression is also observed in the wing. Single expression of either (g,g’) bunA or (h,h’) Madm during 
wing development (by means of C10-Gal4) does not change wing size or curvature visibly. However, their combined expression causes a slight 
overgrowth of the tissue between the wing veins, resulting in a wavy wing surface and wing bending (i’), manifested as folds between wing veins 
in (i) (arrows). Genotypes are: (a) y, w; GMR-Gal4/UAS-eGFP; UAS-lacZ/+; (b) y, w; GMR-Gal4/UAS-eGFP; UAS-bunA/+; (c) y, w; GMR-Gal4/UAS-Madm; 
UAS-lacZ/+; (d) y, w; GMR-Gal4/UAS-Madm; UAS-bunA/+; (f) y, w; UAS-eGFP/+; C10-Gal4/UAS-lacZ; (g) y, w; UAS-eGFP/+; C10-Gal4/UAS-bunA; (h) y, w; 
UAS-Madm/+; C10-Gal4/UAS-lacZ; (i) y, w; UAS-Madm/+; C10-Gal4/UAS-bunA.
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Madm  in  cultured  cells  interfered  with  constitutive 
protein secretion [46,48]. In Xenopus, Madm is important 
for eye development and differentiation [49]. Thus, it is 
apparent that Madm is involved in biological processes 
other than growth control. As a consequence, disruption 
of Madm leads to complex phenotypes partly different 
from bunA phenotypes, and concomitant loss of Madm 
and bunA causes an even stronger growth decrease than 
the single mutants [see Additional file 5]. In addition to 
the Madm growth phenotypes, we observed patterning 
defects, for example in the adult fly eye and wing. Similar 
phenotypes  were  detected  when  bunA  function  was 
absent  or  diminished  [12],  yet  the  patterning  defects 
caused  by  Madm  and  the  Madm  pinhead  phenotype 
appeared  to  be  more  pronounced.  Alternatively,  these 
more pronounced phenotypes could arise from a lower 
protein stability of Madm compared with BunA, leading 
to  more  severe  phenotypes  in  the  eyFLP/FRT  assay. 
However, in contrast to the effects of BunA over  expres-
sion, the overexpression of Madm early during eye and 
wing development led to severe differentiation defects. 
These phenotypes could be caused by Madm-interaction 
partners  other  than  BunA  that  function  in  different 
biological processes.
Madm is an adapter molecule that has several inter-
action partners in mammals. Originally, it was proposed 
that  Madm  -  also  named  nuclear  receptor  binding 
protein 1 (NRBP1) in humans - binds to nuclear receptors 
because of the presence of two putative nuclear-receptor-
binding  motifs  [39].  However,  Madm  has  never  been 
experimentally  shown  to  bind  to  any  nuclear  receptor. 
Furthermore,  the  nuclear-receptor-binding  motifs  are 
not conserved in Drosophila. From studies in mammalian 
cells, it is known that Madm can bind to murine Mlf1 
[40], Jab1 (Jun activation domain-binding protein 1) [50], 
activated Rac3 (Ras-related C3 botulinum toxin substrate 3) 
[47], Elongin B [51], and the host cellular protein NS3 of 
dengue virus type 2 [52]. Indeed, in our AP-MS experi-
ment where HA-Madm was used as bait, we identified 
Elongin B but not Mlf1 (dMlf in Drosophila), Jab1 (CSN5 
in  Drosophila)  or  Rac3  (RhoL  in  Drosophila).  It  is 
possible that these interactions are not very prominent or 
even absent in Drosophila S2 cells.
The Madm-BunA growth-promoting complex
Madm  and  BunA  are  limiting  components  of  a  newly 
identified  growth-promoting  complex  because  genetic 
disruptions of bunA and Madm both result in a reduction 
in  cell  number  and  cell  size.  However,  to  enhance  the 
activity  of  the  complex  and  thereby  to  augment  organ 
growth,  simultaneous  overexpression  of  both  compo-
nents is required. In the reduction-of-function situation, 
we did not detect genetic interactions between bunA and 
Madm.  Thus,  we  hypothesize  that  both  proteins  are 
essential  components  of  a  growth-promoting  complex. 
As a consequence, the phenotype of the limiting protein 
will  be  displayed  no  matter  whether  the  levels  of  the 
other protein are normal or lowered.
It is not clear whether additional proteins are part of 
the  Madm-BunA  growth-regulating  complex.  Hetero-
dimeri  zation partners of BunA or other Madm-binding 
proteins  are  candidate  complex  members.  Conversely, 
Madm-binding partners could form distinct complexes 
mediating  different  functions.  These  complexes  may 
negatively  regulate  each  other  by  competing  for  their 
shared interaction partner Madm. Indeed, we observed a 
suppressive  effect  when  dMlf  or  CSN5  were  co-over-
expressed along with Madm and BunA in the developing 
eye  (data  not  shown).  Thus,  other  Madm-binding 
partners will directly or indirectly influence the growth-
promoting function of the Madm-BunA complex.
We found that GFP-BunA co-localizes with the Golgi 
marker GMAP210 in Drosophila S2 cells. Interestingly, it 
has been suggested that mammalian as well as Drosophila 
Madm plays a role in ER-to-Golgi transport, and it has 
been  reported  that  Madm  localizes  to  the  cytoplasm, 
weakly to the nucleus, and to the Golgi in Drosophila S2 
cells [48]. We observed a similar subcellular localization 
of  both  HA-Madm  and  HA-Madm(R525H)  when 
expressed  at  low  levels  (data  not  shown).  The  Golgi 
localization was lost in cells expressing higher levels of 
HA-Madm, possibly because the cytoplasm was loaded 
with  protein.  Intriguingly,  the  Golgi  localization  of 
HA-Madm,  but  not  of  HA-Madm(R525H),  was  com-
pletely  restored  in  cells  coexpressing  GFP-BunA  and 
HA-Madm at relatively high levels. Thus, BunA is able to 
direct Madm to the Golgi, and the Golgi may be the site 
of action of the Madm-BunA growth-regulating complex. 
However,  because  our  investigation  was  restricted  to 
overexpression  studies,  the  subcellular  localization  of 
endogenous Madm and BunA remains to be analyzed.
How could binding of Madm modulate the function of 
BunA? Madm could have an impact on the stability, the 
activity  or  the  subcellular  localization  of  BunA.  We 
analy  zed the amount of endogenous and overexpressed 
BunA protein in cultured Drosophila cells with dimin-
ished or elevated Madm levels, produced by RNAi with 
double-stranded  RNA  (dsRNA)  or  by  over  expression, 
respectively,  but  did  not  observe  any  effect  (data  not 
shown). Thus, Madm does not fundamentally affect the 
stability of BunA. The putative transcription factor BunA 
localizes  to  the  cytoplasmic  and  not  to  the  nuclear 
fractions in Drosophila [31,46]. Because Madm possesses 
NES and NLS sequences, it is likely to shuttle between 
the cytoplasm and the nucleus [52] and it might therefore 
transport BunA to the nucleus, where BunA could act as 
a  transcription  factor.  So  far,  however,  we  have  not 
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The activity of BunA could be controlled by phosphory-
lation  events,  as  it  has  been  described  for  numerous 
transcription factors. An attractive model is that a kinase 
binding to Madm phosphorylates BunA. An analogous 
model was proposed for murine Mlf1 as Madm binds to 
an  unknown  kinase  that  phosphorylates  Madm  itself 
and a 14-3-3zeta-binding site in Mlf1, possibly resulting 
in  14-3-3-mediated  sequestration  of  Mlf1  in  the 
cytoplasm [40].
Further  studies  will  be  required  to  solve  the  exact 
mechanism  by  which  Madm  and  BunA  team  up  to 
control  growth.  We  anticipate  that  our  findings  will 
encourage studies in mammalian systems on the function 
of long TSC22DF members, in particular TSC22D1.1, in 
growth control.
Conclusions
The mechanism by which the tumor suppressor TSC-22 
acts has remained unclear, and the functional analysis of 
TSC-22 is hampered because of redundancy and various 
possible interactions among the homologous TSC22DF 
proteins.  In  a  previous  study,  we  showed  that  the 
Drosophila  long  class  TSC22DF  isoforms  are  positive 
growth regulators. Here, we report that the long human 
TSC22DF  isoforms  are  able  to  substitute  for  BunA 
function  when  expressed  in  the  fly.  To  illuminate  the 
mechanism by which long TSC22DF isoforms promote 
growth,  we  searched  for  BunA  binding  partners.  A 
combined proteomic and genetic analysis identified the 
adapter protein Madm. Drosophila Madm is a positive 
growth  regulator  that  increases  organ  growth  when 
co-overexpressed with BunA. We propose that the BunA-
Madm  growth-promoting  complex  is  functionally  con-
served from flies to humans.
Materials and methods
Breeding conditions and fly stocks
Flies were kept at 25°C on food described in [53]. For the 
rescue  experiment  bun200B  [12],  UAS-bunA  [31],  arm-
Gal4, da-Gal4, and Act5C-Gal4 (Bloomington Drosophila 
Stock  Center),  and  vas-φC31-zh2A;  ZH-attP-86Fb  [35] 
flies  were  used.  For  the  genetic  mosaic  screen,  y,  w, 
eyFLP; FRT82B, w+, cl3R3/TM6B, Tb, Hu flies [54] were 
used. Clonal analyses in adult eyes were carried out with 
y, w, hsFLP; FRT82B, w+, M/TM6B, Tb, Hu, y+. For rescue 
experiments,  allelic  series,  and  the  analysis  of  hypo-
morphic mutant Madm flies, Df(3R)Exel7283 (Blooming-
ton Drosophila Stock Center) was used. In hypomorphic 
bunA flies displaying wing notches, the alleles bunA-P519L 
[12]  and  bunrI043  [31]  were  combined.  Madm,  bunA 
double-mutant mosaic heads were generated with y, w, 
eyFLP; FRT40A, w+, cl2L3/CyO; FRT82B, w+, cl3R3/TM6B, 
Tb,  Hu  [54]  flies,  bun  allele  A-Q578X  [12],  the  UAS 
hairpin  line  19679  (RNAi  bun)  [55],  and  ey-Gal4  [56]. 
The overexpression studies in the eye and wing were done 
with GMR-Gal4 [57] and C10-Gal4 [58], UAS-eGFP, and 
UAS-lacZ (Bloomington Drosophila Stock Center).
Generation of transgenic flies
bunA cDNA was subcloned from a UAS-bunA plasmid 
[31] into the pUAST-attB vector [35] using EcoRI sites. 
The  bunA  ORF  was  PCR-amplified  from  a  UAS-bunA 
plasmid  [31],  cloned  into  the  pENTR-D/TOPO  vector 
(Invitrogen)  and  subcloned  into  a  Gateway-compatible 
pUAST-attB  vector  (J  Bischof,  Institute  of  Molecular 
Biology,  University  of  Zurich;  unpublished  work)  by 
clonase reaction (LR clonase II enzyme).
The human ORFs TSC22D1.1, TSC22D1.2, TSC22D3v1-3 
and TSC22D4 were derived from the cDNA of a normal 
prostate tissue sample. This sample was derived from a 
radical  prostatectomy  specimen  at  the  Department  of 
Urology, University of Berne as described previously [4]. 
The ORF TSC22D2 was derived from the pOTB7 vector 
carrying  the  TSC22D2  full-length  cDNA  (Open  Bio-
systems, clone ID 5454441). ORFs were PCR-amplified, 
cloned  into  the  pGEM-T  Easy  vector  (Promega)  and 
subsequently cloned into the pcDNA3.1/Hygro(+) vector 
(Invitrogen). The ORFs TSC22D1.1 and TSC22D2 were 
subcloned  from  pGEM-T  Easy  to  pUAST-attB  using 
EcoRI.  The  ORF  TSC22D1.2  was  subcloned  from 
pcDNA3.1/Hygro(+) to the pBluescript II KS(+/-) vector 
using HindIII and XhoI, then further subcloned into the 
pUAST  vector  [34]  using  EcoRI  and  XhoI,  and  finally 
cloned into the pUAST-attB vector with EcoRI and XbaI. 
The  ORFs  TSC22D3v1-3  and  TSC22D4  were  PCR-
amplified from cDNA-containing pGEM-T Easy plasmids 
and cloned into pUAST-attB using EcoRI and NotI (restric-
tion sites added by PCR). The pUAST-attB plasmids were 
injected into vas-φC31-zh2A; ZH-attP-86Fb embryos [35].
Madm cDNA was cleaved by EcoRI and HindIII double 
digestion  from  expressed  sequence  tag  (EST)  clone 
LD28567  (Berkeley  Drosophila  Genome  Project)  and 
subcloned into pUAST using the same restriction sites to 
generate  the  UAS-Madm  construct.  Madm  genomic 
DNA (from 559 bp upstream of Madm exon 1 (containing 
exon  1  of  the  neighboring  gene  CG2097)  to  1,681  bp 
downstream  of  Madm  exon  2)  was  amplified  by  PCR 
using  forward  primer  GCT  CTA  GAA  GGC  GAT  GCG­
ATG  ACCAGCTC  and  reverse  primer  GAG  ATC  TTC-
ATG  ACGTTTTCCGCGCACTCGAGT. The PCR product 
was digested with BglII and XbaI and subcloned into the 
transformation vector pCaspeR.
Gateway cloning for Drosophila cell culture and yeast 
two-hybrid assays
The complete and partial ORFs of bunA and Madm were 
PCR-amplified from a pUAST-bunA [31] and a UAS-Madm 
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TOPO vector. The point mutations in pENTR-D/TOPO-
bunA and -Madm were introduced by substitution of a 
BamHI/DraI and an FspI/SacI fragment that was PCR-
amplified using mutated primers. By clonase reaction (LR 
clonase II) the inserts were transferred to the following 
destination vectors: pMT-HHW-Blast (O Rinner, IMSB, 
ETH  Zurich,  unpublished  work),  pMT-GW-Blast, 
pDEST22, and pDEST32. Additionally, the GFP ORF was 
cloned into the pMT-HHW-Blast vector, leading to the 
production of HA-tagged GFP as a negative control for 
co-IP experiments. The pMT-HHW-Blast vector is based 
on  the  pMT-V5HisA  vector  (Invitrogen)  carrying  a 
metallothionein-inducible  promoter.  The  multiple 
cloning  site  and  tag  sequences  were  replaced  by  the 
Gateway  cassette,  including  the  coding  sequence  for  a 
triple  HA-tag  from  the  pAHW  destination  vector 
(Invitro  gen).  The  blasticidin-resistance  cassette  was 
cloned  from  the  pCoBlast  vector  (Invitrogen)  into  the 
pMT-V5HisA  vector  backbone.  The  pMT-HHW-Blast 
vector  was  modified  by  exchanging  an  AgeI/EcoRI 
fragment containing the GFP coding region derived from 
the pAGW destination vector.
Cell culture conditions and cell transfections
Drosophila  embryonic  S2  cells  were  grown  at  25°C  in 
Schneider’s  Drosophila  medium  (Gibco/Invitrogen) 
supple  mented with 10% heat-inactivated fetal calf serum 
(FCS),  as  well  as  penicillin  and  streptomycin.  S2  cells 
were transfected according to the Effectene transfection 
protocol for adherent cells (Qiagen). To generate stable 
cell lines, transfected S2 cells were selected for 14-30 days 
in Schneider’s medium containing 25 μg/ml blasticidin 
and  afterwards  propagated  in  Schneider’s  medium 
containing 10 μg/ml blasticidin.
Pulldown experiments analyzed by LC-MS/MS
Before  affinity  purification,  Drosophila  S2  cells  were 
grown in shaking flasks. Bait expression was induced by 
600 μM CuSO4 for at least 16 h. For affinity purification 
the cell pellets were lysed on ice for 30 minutes in 10 ml 
HNN (50 mM HEPES pH 7.5, 5 mM EDTA, 250 mM 
NaCl,  0.5%  NP40,  1  mM  PMSF,  50  mM  NaF,  1.5  mM 
Na3VO4,  protease  inhibitor  cocktail  (Roche))  in  the 
presence  of  3  mM  dithiobis-(succinimidyl  propionate) 
(DSP)  with  ten  strokes  using  a  tight-fitting  Dounce 
homogenizer. Reactive DSP was quenched by adding 1 ml 
Tris pH 7.5. Insoluble material was removed by centrifu-
gation and the supernatant was precleared using 100 μl 
Protein A-Sepharose (Sigma) for 1 h at 4°C on a rotating 
shaker. After removal of the Protein A-Sepharose, 100 μl 
Agarose anti-GFP beads (MB-0732) or Agarose mono-
clonal mouse anti-HA beads (Sigma A2095) were added 
to the extracts and incubated for 4 h at 4°C on a rotating 
shaker. Immunoprecipitates were washed four times with 
20  bed  volumes  of  lysis  buffer  and  three  times  with 
20 bed volumes of buffer without detergent and protease 
inhibitor. The proteins were released from the beads by 
adding three times 150 μl 0.2 M glycine pH 2.5. Following 
neutralization with 100 μl 1 M NH4CO3, the eluates were 
treated with 5 mM tris(2-carboxyethyl)phosphine (TCEP) 
to reduce S-S bonds and DSP crosslinkers for 30 minutes 
at  37°C,  and  alkylated  with  10  mM  iodoacetamide  for 
30 minutes at room temperature in the dark. For tryptic 
digestion,  1  μg  trypsin  was  added  to  the  eluate  and 
incubated at 37°C overnight.
Nanoflow-LC-MS/MS was performed by coupling an 
UltiMate  HPLC  system  (LC-Packings/Dionex)  in-line 
with a Probot (LC-Packings/Dionex) autosampler system 
and an LTQ ion trap (Thermo Electron). Samples were 
automatically  injected  into  a  10-μl  sample-loop  and 
loaded onto an analytical column (9 cm × 75 μm; packed 
with  Magic  C18  AQ  beads  5  μm,  100  Å  (Michrom 
BioResources)). Peptide mixtures were delivered to the 
analytical column at a flow rate of 300 nl/minute of buffer 
A (5% acetonitrile, 0.2% formic acid) for 25 minutes and 
then  eluted  using  a  gradient  of  acetonitrile  (10-45%; 
0.5%/minutes)  in  0.2%  formic  acid.  Peptide  ions  were 
detected in a survey scan from 400 to 2,000 atomic mass 
units (amu; one to two μscans) followed by three to six 
data-dependent MS/MS scans (three μscans each, isola-
tion width 2 amu, dynamic exclusion list 250, dynamic 
exclusion  time  240  sec,  two  repeats)  in  an  automated 
fashion.  Following  analysis,  raw  MS/MS  data  were 
converted  to  Mascot  generic  format  (MGF)  files  that 
were used to identify the corresponding peptides using 
the Mascot database search tool (MatrixScience) [59,60]. 
MS/MS  spectra  were  searched  against  the  Drosophila 
protein  database  (dmel_r5.18_FB2009_05  released 
20090529) [60] with the following criteria: requirement 
for  trypsin  digestion;  peptide  mass  tolerance  2  Da; 
fragment  mass  tolerance  0.6  Da;  missed  cleavage  for 
trypsin  3;  fixed  modification  carbamidomethyl  (C); 
variable  modifications  acetyl  (N-term),  oxidation  (M), 
CAM-thiopropanoyl (K) (derived from DSP crosslinker). 
All  peptide  assignments  with  Mascot  ion  score  larger 
than the homology score and with Mascot expect score 
smaller than 0.05 (significant ion score) were considered 
as good hits.
Co-localization studies
For  immunofluorescence  Drosophila  S2  cells  were 
stimu  lated for 4 h with 600 μM CuSO4 and spread on 
concanavalin-A-treated slides and fixed with 4% para-
formaldehyde. Mouse anti-HA (1:200, Roche 166606), 
rabbit anti-GMAP210 (1:200) [38], goat anti-mouse Cy3 
(1:200, Amersham PA43002) and goat anti-rabbit Cy3 
(1:200,  Amersham  PA43004)  antibodies  were  used. 
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For imaging, a Leica TCS SPE confocal microscope was 
used.
Statistical  analysis  of  the  dependence  of  HA-Madm 
localization  on  GFP-BunA  was  carried  out  in  S2  cells 
transiently  transfected  two  days  before  analysis.  Cells 
were co-transfected with pMT-HA-Madm or pMT-HA-
Madm(R525H)  and  with  either  empty  pMT-GW-Blast 
(for  control  GFP  expression)  or  with  pMT-GFP-bunA. 
Fifty  cells  were  analyzed  for  each  combination.  The 
expressed  HA-Madm  and  HA-Madm(R525H)  proteins 
showed a similar diffuse localization in the cytoplasm of 
cells  strongly  expressing  GFP  (50  out  of  50  each).  By 
contrast, HA-Madm localized to dots (punctae) in cells 
displaying a readily detectable GFP-BunA signal (50 out 
of  50).  In  17  out  of  50  cells,  GFP-BunA  directed 
HA-Madm(R525H) localization in punctae.
GPF-tagged versions of BunA and Madm
To  generate  flies  expressing  amino-terminally  GFP-
tagged versions of BunA and Madm, the respective ORFs 
were  subcloned  by  clonase  reaction  from  pENTR/D-
TOPO  to  pUAST-GW-AttB  (the  Gateway-compatible 
pUAST-AttB vector was provided by I Pörnbacher, IMSB, 
ETH Zurich; unpublished work). The plasmid containing 
bunA  was  injected  into  vas-φC31-zh2A;  ZH-attP-86Fb 
embryos  [35],  and  the  Madm-containing  plasmid  into 
vas-φC31-zh2A;  ZH-attP-51D  embryos  [35].  Leaky 
expression of UAS-GFP-bunA was sufficient to completely 
rescue the lethality of bun200B/200B mutants. Expression of 
UAS-GFP-Madm  under  the  control  of  the  arm-Gal4 
driver line resulted in a rescue (approximately 50% of the 
expected Mendelian ratio) of the lethality of Madm3Y2/
Df(3R)Exel7283 animals.
Co-immunoprecipitation and western blotting
Stable Drosophila S2 cell lines capable of producing GFP 
(negative  control)  or  GFP-tagged  Bun  versions  were 
transiently  transfected  with  HA-Madm  plasmids.  Two 
days after transient transfection, confluent Drosophila S2 
cells (2.3 ml corresponding to one well of a 6-well-plate) 
were induced for 4 h with CuSO4 (600 μM), harvested, 
and washed with PBS. Cells were lysed in IP buffer (120 
mM  NaCl,  50  mM  Tris  pH  7.5,  20  mM  NaF,  1  mM 
benzamidine,  1  mM  EDTA,  6  mM  EGTA,  15  mM 
Na4P2O7, 0.5% Nonidet P-40, 1x Complete Mini Protease 
Inihibitor (Roche)). After incubation for 15 minutes on 
an  orbital  shaker  at  4°C,  solubilized  material  was 
recovered by centrifugation at 13,000 rpm for 15 minutes 
and supernatants were collected. Cell lysates were incu-
bated  for  4  h  at  4°C  under  rotation  either  with  20  μl 
Agarose anti-GFP beads (MB-0732) or Agarose mono-
clonal  mouse  anti-HA  beads  (Sigma  A2095)  that  had 
been equilibrated with IP buffer. Beads were then washed 
five times with IP buffer and boiled for 5 minutes at 95°C 
in Laemmli buffer. Proteins contained in the supernatant 
were separated by SDS-PAGE. For western blotting, the 
Hybond ECL Nitrocellulose membrane (Amersham), the 
ECL  detection  reagent  (Amersham),  and  the  following 
antibodies  were  used:  rabbit  anti-Bun  (1:1,000)  [33], 
rabbit anti-BunA (1:2,000), mouse anti-HA (1:3,000, Roche 
166606), monoclonal mouse anti-GFP (1:1,000, Roche 11 
814 460 001), monoclonal mouse anti-rabbit horseradish 
peroxidase  (HRP)  (1:10,000,  Jackson  Lab),  sheep  anti-
mouse HRP (1:10,000, Amersham NA931).
The rabbit anti-BunA antibody was generated using the 
following  peptide  to  immunize  rabbits:  H2N-
TNRKPKTTSSFEC-CONH2  (Eurogentec).  The  serum 
was double-affinity purified against the peptide coupled 
to a column. Specificity of the antibody was shown by 
western blotting: Drosophila S2 cells were incubated for 
2 days with dsRNA [61] that targets either the ORF of 
bunA (500 bp long dsRNA) or of GFP as a control (700 bp 
long dsRNA). Primer sequences are available on request.
Yeast two-hybrid experiments
For  the  Y2H  experiments  the  Gateway-compatible 
ProQuest Two-Hybrid System (Invitrogen) including the 
pDEST32  and  pDEST22  vectors  was  used.  Trans  for-
mation of a MaV203 strain was achieved with the LiAc/
SS  carrier  DNA/polyethylene  glycol  (PEG)  method.  To 
identify  interactions,  yeast  cells  were  tested  for  HIS3 
reporter gene expression under the control of the HIS 
promoter.  The  competitive  inhibitor  3-amino-1,2,4-
triazole  (3-AT)  was  used  to  dampen  leaky  expression. 
The 3-AT concentration needed to restrain leakiness was 
determined  to  be  10  mM  by  almost  suppressing  the 
growth  of  negative  control  strains  that  have  been 
transformed with an empty pDEST22 and/or pDEST32 
vector  (every  combination  of  negative  controls  was 
examined). For each interaction to be tested, five yeast 
colonies were pooled and grown overnight in -Leu -Trp 
medium. Seven microliters of dilutions of OD600 = 0.1, 
0.01, and 0.001 with double-distilled H2O were spotted 
on -Leu -Trp -His +3-AT (10 mM) plates and incubated 
for 52-56 h at 30°C. As a control for a correct dilution 
series they were also spotted on -Leu -Trp -His plates 
without 3-AT (data not shown).
eyFLP/FRT screen, mapping of EMS mutations, and rescue 
experiments
The  eyFLP/FRT  technique  [54]  was  used  to  produce 
mosaic flies with eyes and head capsules largely homo  zy-
gous  for  randomly  induced  mutations.  The  rest  of  the 
body  (including  the  germline)  remained  heterozygous 
and  was  therefore  phenotypically  wild  type  (screen 
described in [41]). The seven EMS alleles of a comple-
men  tation  group  on  3R  were  mapped  using  visible 
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With deletions that failed to complement the lethality of 
EMS  alleles  (Df(3R)ED5196,  Df(3R)ED5197,  Df(3R)
Exel7283, and Df(3R)Exel6145) the candidate region was 
narrowed down to the cytological interval 83C1-4. The 
EP-element EP3137 inserted in the 5’ untranslated region 
of the Madm locus failed to complement the lethality of 
the EMS alleles.
The UAS/Gal4 system [34] was used to test whether 
ubiquitous expression of a UAS-Madm construct during 
development - achieved by the arm-Gal4, da-Gal4, and 
Act5C-Gal4 driver lines - rescued the recessive lethality 
of  the  EMS  alleles.  Using  arm-Gal4,  the  viability  of 
combinations of EMS alleles (2U3, 3G5, 3Y2, and 7L2) 
with  the  deletion  Df(3R)Exel7283  was  completely 
restored and the lethality of heteroallelic combinations 
among EMS alleles was partially rescued. One copy of a 
genomic Madm rescue construct (LCQ139) - comprising 
559 bp of the upstream region, the two Madm exons and 
the intron, and 1,681 bp of downstream sequences - was 
sufficient to entirely rescue the lethality of heteroallelic 
combinations of EMS alleles (2U3 and 3G5) and of the 
hemizygous  alleles  (tested  with  the  deficiency  Df(3R)
Exel7283).  In  addition,  the  pinhead  phenotypes  of  the 
EMS alleles 2U3 and 3G5 were reverted by one copy of 
the genomic construct.
Determination of allelic series
Animals were reared on apple agar plates supplemented 
with  yeast  at  25°C.  Allelic  series  was  determined  by 
crossing  Madm  EMS  alleles  (y,  w;  FRT82B,  Madm-/
TM6B,  Tb,  Hu)  to  a  defi  ciency  (y,  w;  Df(3R)Exel7283/
TM6B, Tb, Hu) uncovering the entire Madm locus. In 
addition,  the  development  of  Madm2U3/3G5  and 
Madm3Y2/7L2 animals was compared with the development 
of  Madm2U3  or  3G5/Df(3R)Exel7283  and  Madm3Y2  or  7L2/
Df(3R)Exel7283  animals,  respectively.  Heteroallelic 
combinations of the Madm EMS alleles, except for 3T4, 
resulted in larval phenotypes that were as strong as the 
phenotypes caused in the hemizygous condition.
Analysis of adult flies
Clones in the adult eyes were induced 24-48 h after egg 
deposition  (AED)  by  a  heat  shock  for  1  h  at  34°C  in 
animals of the genotype y, w, hsFLP/y, w; FRT82B, w+, 
M/ FRT82B, Madm-. Adult fly heads were halved using 
a razor blade and stored up to 1 h in Ringer’s solution 
on ice. Eyes were then fixed and processed as described 
in  [62].  Pictures  were  taken  with  a  Zeiss  Axiophot 
micro  scope.  In  tangential  eye  sections,  the  areas 
enclosed  by  rhabdomeres  and  cell  bodies  from 
photoreceptors  R1-R6  were  measured  in  mutant 
ommatidia  (lacking  pigmenta  tion)  and  in  neighboring 
wild-type  sized  (pigmented)  ommatidia  using  Adobe 
Photoshop.  Student’s  t-test  was  used  to  determine 
significance.
For the analysis of the ommatidia number in mosaic 
eyes and the analysis of ommatidia size in overexpression 
studies,  flies  were  frozen  at  -20°C  before  taking  SEM 
pictures.  All  ommatidia  were  counted  and  the  area  of 
seven  adjacent  ommatidia  (rosette)  in  the  center  was 
measured using Adobe Photoshop.
Freshly eclosed hypomorphic mutant Madm flies were 
kept on fresh food for 2 days. Flies were exposed to 95°C 
for 5 minutes and air-dried at room temperature for 3 
days. The dry weight of individual flies was determined 
with a Mettler Toledo MX5 microbalance. Significance 
was assessed using Student’s t-test.
Adult wings were mounted in Euparal after dehydration 
in  70%  and  subsequently  100%  ethanol.  Pictures  were 
taken  with  a  Zeiss  Axiophot  microscope.  Significance 
was assessed using Student’s t-test.
For the overexpression studies, a set of Gal4 driver lines 
was crossed to a UAS-Madm transgenic line. No obvious 
phenotypes  were  observed  using  arm-Gal4,  da-Gal4, 
ppl-Gal4,  and  sev-Gal4.  Ubiquitous  overexpression 
achieved with Act5C-Gal4 resulted in lethality. Expres-
sion in the dorsal compartment of the developing wing 
(ap-Gal4) led to deformed wings. MS1096-Gal4 directed 
expression in the developing wing produced vein defects 
and  blisters  in  the  adult  wing.  Expression  of  Madm 
during  early  eye  development  (ey-Gal4)  produced 
pattern  ing defects (rough and small adult eyes) whereas 
Madm expression later during eye development (GMR-
Gal4)  produced  growth  phenotypes  when  co-over-
expressed with UAS-bunA.
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